Literature DB >> 4346665

Peripheral neuropathy with ethambutol.

P Tugwell, S L James.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1972        PMID： 4346665      PMCID： PMC2495333          DOI： 10.1136/pgmj.48.565.667

Source DB:  PubMed          Journal:  Postgrad Med J        ISSN： 0032-5473            Impact factor:   2.401


× No keyword cloud information.
  5 in total

1.  Clinical experience with ethambutol.

Authors:  T M Wilson
Journal:  Antibiot Chemother       Date:  1970

2.  Pharmacological and biochemical studies on ethambutol in laboratory animals.

Authors:  D A Buyske; E Peets; W Sterling
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

3.  Central nervous system effects of ethambutol in monkeys.

Authors:  I G Schmidt
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691

4.  The undesired side-effects of Myambutol.

Authors:  H Tiburtius
Journal:  Antibiot Chemother       Date:  1970

5.  The ocular toxicity of ethambutol and its relation to dose.

Authors:  J E Leibold
Journal:  Ann N Y Acad Sci       Date:  1966-04-20       Impact factor: 5.691
  5 in total
  11 in total

Review 1.  HIV-associated neuropathic pain: epidemiology, pathophysiology and management.

Authors:  Susama Verma; Lydia Estanislao; David Simpson
Journal:  CNS Drugs       Date:  2005       Impact factor: 5.749

2.  Two cases of ethambutol nephrotoxicity.

Authors:  J Collier; A M Joekes; P E Philalithis; F D Thompson
Journal:  Br Med J       Date:  1976-11-06

3.  Drug-induced peripheral neuropathies.

Authors:  Z Argov; F L Mastaglia
Journal:  Br Med J       Date:  1979-03-10

4.  Cycloserine Induced Late Onset Psychosis and Ethambutol Induced Peripheral Neuropathy Associated with MDR-TB Treatment in an Indian Patient- A Rare Case Report.

Authors:  Sadhana Holla; Mohan Babu Amberkar; Rajeshkrishna Bhandarypanambur; Meenakumari Kamalkishore; Manju Janardhanan
Journal:  J Clin Diagn Res       Date:  2015-02-01

5.  Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.

Authors:  Masamichi Goto; Kazue Nakanaga; Thida Aung; Tomofumi Hamada; Norishige Yamada; Mitsuharu Nomoto; Shinichi Kitajima; Norihisa Ishii; Suguru Yonezawa; Hajime Saito
Journal:  Am J Pathol       Date:  2006-03       Impact factor: 4.307

Review 6.  Nervous system effects of antituberculosis therapy.

Authors:  Joseph S Kass; Wayne X Shandera
Journal:  CNS Drugs       Date:  2010-08       Impact factor: 5.749

7.  Myelopathy during treatment for pulmonary tuberculosis.

Authors:  A C Reid; I Bone
Journal:  Postgrad Med J       Date:  1980-07       Impact factor: 2.401

Review 8.  Prevention and management of drug-induced peripheral neuropathy.

Authors:  L L Olesen; T S Jensen
Journal:  Drug Saf       Date:  1991 Jul-Aug       Impact factor: 5.606

9.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

10.  Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?

Authors:  Mark Stettner; Daniela Steinberger; Christian J Hartmann; Tatjana Pabst; Lidija Konta; Hans Peter Hartung; Bernd C Kieseier
Journal:  Brain Behav       Date:  2015-05-29       Impact factor: 2.708
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.